| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) | 
|---|
| 09/16/2014 | CA2504532C Botulinum neurotoxin b receptors and use thereof  | 
| 09/16/2014 | CA2494368C Seed-associated promoter sequences  | 
| 09/16/2014 | CA2492556C Hsp70 from arthrobacter  | 
| 09/16/2014 | CA2445796C Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system  | 
| 09/16/2014 | CA1341640C Recombinant fibroblast growth factors  | 
| 09/15/2014 | CA2809714A1 Infectious genomic dna clone and serological profile of torque teno sus virus 1 and 2  | 
| 09/12/2014 | WO2014138687A1 Peptides and compositions for treatment of joint damage  | 
| 09/12/2014 | WO2014138371A1 Host cells and methods of use  | 
| 09/12/2014 | WO2014138348A1 Iikaros inhibition to augment adoptive t cell transfer  | 
| 09/12/2014 | WO2014138318A1 Waterborne aqueous-alcohol soluble protein compositions, applications and methods  | 
| 09/12/2014 | WO2014137572A1 Regulation of specific spinal neurons regulating pain transmission  | 
| 09/12/2014 | WO2014137161A1 Improved preparation method for high-yield production of physiologically active polypeptide conjugate  | 
| 09/12/2014 | WO2014136971A1 Method for producing compound containing heterocycle  | 
| 09/12/2014 | WO2014136453A1 C12orf48 PEPTIDES AND VACCINES CONTAINING THE SAME  | 
| 09/12/2014 | WO2014136118A1 Treatment of post-traumatic stress disorder with melanocortin receptor antagonist  | 
| 09/12/2014 | WO2014136117A1 USE OF PLANT CELLS EXPRESSING A TNFalpha POLYPEPTIDE INHIBITOR IN THERAPY  | 
| 09/12/2014 | WO2014136114A1 TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME  | 
| 09/12/2014 | WO2014136113A1 Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same  | 
| 09/12/2014 | WO2014136065A2 Production of catalytically active type i sulfatase  | 
| 09/12/2014 | WO2014136064A2 Immunogenic fusion polypeptides  | 
| 09/11/2014 | US20140259231 Multi-Gene Expression Vehicle  | 
| 09/11/2014 | US20140259226 Constitutively active aba receptor mutants  | 
| 09/11/2014 | US20140259218 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement  | 
| 09/11/2014 | US20140259217 Polynucleotides and polypeptides involved in post-transcriptional gene silencing  | 
| 09/11/2014 | US20140259216 Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism  | 
| 09/11/2014 | US20140259215 Method for expressing deoxyribonuclease in plants  | 
| 09/11/2014 | US20140259197 Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism  | 
| 09/11/2014 | US20140256917 Compositions and methods for osteogenic gene therapy  | 
| 09/11/2014 | US20140256914 Production of pulse protein product  | 
| 09/11/2014 | US20140256913 Msp nanopores and related methods  | 
| 09/11/2014 | US20140256912 Stabilized Variant MAML Peptides and Uses Thereof  | 
| 09/11/2014 | US20140256802 Dual-AAV Vector-Based Systems and Methods for Delivering Oversized Genes to Mammalian Cells  | 
| 09/11/2014 | US20140256800 Fev mini-promoters  | 
| 09/11/2014 | US20140256652 Polypeptides Involved In Immune Response  | 
| 09/11/2014 | US20140256643 Peptides and compositions for treatment of joint damage  | 
| 09/11/2014 | US20140256640 Treatment of coagulopathy with hyperfibrinolysis  | 
| 09/11/2014 | US20140256636 Pegylated hemoglobin and albumin and uses thereof  | 
| 09/11/2014 | US20140256635 Anti-angiogenic molecules, nanostructures and uses thereof  | 
| 09/11/2014 | US20140256630 Vegf-specific capture agents, compositions, and methods of using and making  | 
| 09/11/2014 | US20140256621 Engineered poypeptides having enhanced duration of action and reduced immunogenicity  | 
| 09/11/2014 | US20140256613 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same  | 
| 09/11/2014 | US20140255992 Process For Production Of Recombinant Human Growth Hormone  | 
| 09/11/2014 | US20140255988 MONOMERIC VARIANTS OF THE TETRAMERIC eqFP611  | 
| 09/11/2014 | US20140255957 Antigens Derived from Citrullinated 14-3-3 and Uses Thereof in the Diagnosis of Rheumatoid Arthritis  | 
| 09/11/2014 | US20140255712 Method for coating substrates with at least one monolayer of self-assembling proteins  | 
| 09/11/2014 | US20140255518 Treatment and Prevention of Gastrointestinal Syndrome  | 
| 09/11/2014 | US20140255513 Lytic domain fusion constructs and methods of making and using same  | 
| 09/11/2014 | US20140255476 Compositions, devices, and methods for treating infections  | 
| 09/11/2014 | US20140255468 Modified polynucleotides encoding programmed cell death 1  | 
| 09/11/2014 | US20140255467 Modified polynucleotides encoding cytotoxic t-lymphocyte-associated protein 4  | 
| 09/11/2014 | US20140255455 Methods for the production of a cosmetic composition comprising leukolectin and uses thereof  | 
| 09/11/2014 | US20140255443 Nucleic Acid And Amino Acid Sequences Relating To Streptococcus Pneumoniae For Diagnostics And Therapeutics  | 
| 09/11/2014 | US20140255441 Vlps containing ligands and methods related thereto  | 
| 09/11/2014 | US20140255438 Fusion proteins and methods of use  | 
| 09/11/2014 | US20140255435 Vaccine  | 
| 09/11/2014 | US20140255434 Phl p 5a derivatives having reduced allergeneity and retained t-cell reactivity  | 
| 09/11/2014 | US20140255421 Methods and Compositions for Treating Polyps  | 
| 09/11/2014 | US20140255416 Peptides derived from Camplobacter jejuni and their use in vaccination  | 
| 09/11/2014 | US20140255403 Oral composition comprising a tnf antagonist and use thereof  | 
| 09/11/2014 | US20140255401 Kv1.3 Antagonists and Methods of Use  | 
| 09/11/2014 | US20140255400 Arginine-free tnfr:fc-fusion polypeptide compositions and methods of use  | 
| 09/11/2014 | US20140255399 Separation method for fucosylated antibodies  | 
| 09/11/2014 | US20140255393 Compositions and methods for autoimmune disease  | 
| 09/11/2014 | US20140255389 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics  | 
| 09/11/2014 | US20140255361 Estrogen-receptor based ligand system for regulating protein stability  | 
| 09/11/2014 | US20140255349 Peptides with viral infection enhancing properties and their use  | 
| 09/11/2014 | US20140255345 Amino acid substituted molecules  | 
| 09/11/2014 | US20140255343 Dna vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the h5 haemagglutinin of an influenza virus and use of the dna vaccine  | 
| 09/11/2014 | US20140255338 Edar ligand derived peptides and use thereof  | 
| 09/11/2014 | US20140255317 Preparation comprising hexose-6-phosphate-modified cholesterol derivative  | 
| 09/11/2014 | US20140255310 Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 Expression  | 
| 09/10/2014 | EP2775303A1 Method for detecting chronic sinusitis  | 
| 09/10/2014 | EP2775301A1 Indirect antigen-specific lymphocyte recognition assay  | 
| 09/10/2014 | EP2774994A1 Undifferentiated cell detection method and complex carbohydrate detection method  | 
| 09/10/2014 | EP2774935A1 Improved neurturin molecules  | 
| 09/10/2014 | EP2774934A1 Polypeptide solution, artificial polypeptide fiber production method using same, and polypeptide refining method  | 
| 09/10/2014 | EP2773766A1 In vivo adcc model  | 
| 09/10/2014 | EP2773764A1 Plants having increased tolerance to herbicides  | 
| 09/10/2014 | EP2773763A1 Plants having increased tolerance to herbicides  | 
| 09/10/2014 | EP2773762A1 Improving plant drought tolerance, nitrogen use efficiency and yield  | 
| 09/10/2014 | EP2773755A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same  | 
| 09/10/2014 | EP2773674A1 Immunologic constructs and methods  | 
| 09/10/2014 | EP2773660A2 Chimeric human-camel antigens and their use  | 
| 09/10/2014 | EP2773659A2 Fibronectin binding domains with reduced immunogenicity  | 
| 09/10/2014 | EP2773658A1 Modulating beta-damascenone in plants  | 
| 09/10/2014 | EP2773657A1 MtNIP REGULATED PLANTS WITH SIGNIFICANTLY INCREASED SIZE AND BIOMASS  | 
| 09/10/2014 | EP2773656A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same  | 
| 09/10/2014 | EP2773655A1 Protective vaccine based on staphylococcus aureus sa2074 protein  | 
| 09/10/2014 | EP2773654A1 Peptides and methods for the detection of lyme disease antibodies  | 
| 09/10/2014 | EP2773427A2 Medical use  | 
| 09/10/2014 | EP2773369A1 Compositions and methods for preventing and treating oral diseases  | 
| 09/10/2014 | EP2773368A1 Inhibition of collagen synthesis  | 
| 09/10/2014 | EP2773221A1 Simultaneous purification of cell components  | 
| 09/09/2014 | USRE45123 Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis  | 
| 09/09/2014 | US8829295 Soybean cultivar 28241823  | 
| 09/09/2014 | US8829293 Soybean cultivar 22170671  | 
| 09/09/2014 | US8829290 Soybean cultivar 23210992  | 
| 09/09/2014 | US8829279 Family of pesticidal proteins and methods for their use  | 
| 09/09/2014 | US8829274 Schizochytrium PKS genes  | 
| 09/09/2014 | US8829176 Beta-actin and RPS21 promoters and uses thereof  |